Edition:
India

Innate Pharma SA (IPH.PA)

IPH.PA on Paris Stock Exchange

5.49EUR
16 Jan 2018
Change (% chg)

-- (--)
Prev Close
€5.49
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
367,464
52-wk High
€15.48
52-wk Low
€4.33

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 15.55 -0.433
FY 2016 Dec '16 39.50 0.293
Jun '16 16.66 -0.059
 
*Note: Units in Millions ofEuro
**Note: Units in Euro

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 6 46.37 64.90 19.20 57.90
Earnings (per share)
Year Ending Dec-18 7 -0.19 1.03 -1.10 0.30
LT Growth Rate (%) 1 63.70 63.70 63.70 --
Sales and Profit Figures in Euro (EUR);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 213.63 65.14 49.76
EPS (TTM) % 286.85 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Innate Pharma SA

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -5.23 -9.58 99 --
13 Week -2.14 -6.06 99 --
26 Week -6.57 -10.49 99 --
52 Week -8.20 -23.27 99 --
YTD -27.99 -34.68 93 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 23.26%
# of Holders: 67
Total Shares Held: 13,343,087
3 Mo. Net Change: -560,327
# New Positions: 0
# Closed Positions: 4
# Increased Positions: 6
# Reduced Positions: 9
# Net Buyers: -3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.